期刊文献+

复发性宫颈癌组织间插植并腔内近距离调强适形放射治疗效果分析 被引量:10

Efficacy of interstitial implantation and lumen intensity-modulated conformal brachytherapy for recurrent cervical cancer patients
原文传递
导出
摘要 目的探讨组织间插植并腔内近距离调强适形放射治疗复发性宫颈癌疗效及毒副反应。方法 65例手术+放疗与根治性放疗后复发的宫颈癌采用不同治疗方法,A组37例采用组织间插植+腔内近距离调强适形放射治疗,B组28例采用三维适形+传统腔内放射治疗,比较A、B两组的疗效差异与毒副反应。结果 A组37例复发性宫颈癌完全缓解+部分缓解33例、稳定+进展4例;B组28例复发性宫颈癌完全缓解+部分缓解18例、稳定+进展10例,两组近期疗效比较有统计学意义(χ2=5.849,P=0.016)。1、2、3年局控率,A组分别为86.2%、73.7%、43.7%,B组分别为77.7%、59.6%、11.8%,差异有统计学意义(χ2=4.575,P=0.032);1、2、3年生存率,A组分别为88.5%、75.4%、47.6%,B组分别为78.2%、60.0%、23.8%,差异有统计学意义(χ2=4.140,P=0.042)。毒副反应:放射性膀胱炎发生率A、B两组分别为10.8%、32.1%,差异有统计学意义(χ2=4.533,P=0.033);放射性直肠炎发生率A、B两组分别为13.5%、39.3%,差异有统计学意义(χ2=5.705,P=0.017);放射性盆腔纤维化发生率A、B两组分别为13.5%、14.3%,差异无统计学意义(χ2=0.008,P=0.929)。结论复发性宫颈癌组织间插植+腔内近距离调强适形放射治疗与体外三维适形放疗+传统腔内放射治疗相比有明显优势,具有疗效好、疗程短、毒副反应轻的特点。 Objective To investigate the curative effect and toxicity of interstitial implantation intensity modulated brachytherapy for recurrent cervical cancer. Methods 65 recurrent patients with cervical cancer that have received radical surgery+radiotherapy or radiotherapy were treated with different methods,Group A(37 cases)were treated with interstitial implantation+intensity-modulated conformal brachytherapy,and Group B(28 cases)with three-dimensional conformal radiotherapy+intracavitary radiotherapy,the differences of curative effect and toxicity of two group were compared.Results There were 33 cases CR+PR,4 cases SD+PD in Group A,and 18 cases CR+PR,10 cases SD+PD in Group B,difference of short-term curative effect has statistical significance(χ2=5.849,P=0.016).The local control rates of 1-,2-,3-years in Group A are 86.2%,73.7%,43.7%,and 77.7%,59.6%,11.8% in Group B respectively,the difference has statistical significant(χ2=4.575,P=0.032);The survival rates of 1-,2-,3-years in Group A are 88.5%,75.4%,47.6%,and 78.2%,60.0%,23.8% in Group B respectively,the difference has statistical significant(χ2=4.140,P=0.042);Toxicity:The incidences of radiation cystitis in Group A and B were 10.8%,32.1%,the difference has statistical significant (χ2=4.533,P=0.033);the incidences of radiation proctitis in Group A and B were 13.5%,39.3%,the difference has statistical significant(χ2=5.705,P=0.017);the incidences of radiation pelvic Group A and B were 13.5%,14.3%,the difference has fibrosis in not statistical significant(χ2=0.008,P=0.929).Conclusions Compared with three-dimensional conformal+intracavitary radiotherapy,the interstitialimplantation+ intensity-modulated conformal brachytherapy for recurrent cervical cancer patients has obviously advantages,and has the characteristics of good curative effect,short course,mild side-effect.
出处 《中华临床医师杂志(电子版)》 CAS 2011年第7期1896-1900,共5页 Chinese Journal of Clinicians(Electronic Edition)
关键词 宫颈肿瘤 近距离放射疗法 放射疗法 调强适形 组织间插植 Uterine cervical neoplasms Brachytherapy Radiotherapy,intensity-modulated Inter-organizational
  • 相关文献

参考文献13

  • 1唐虹,杨越波,沈慧敏.影响子宫颈癌复发的高危因素分析[J].中国实用医药,2010,5(26):28-30. 被引量:7
  • 2田种泽,李莎,刘茗露,朱向辉,赵瑞,岳养军,陈小华.宫颈癌放射治疗预后因素分析[J].中华临床医师杂志(电子版),2010,4(8):156-158. 被引量:3
  • 3叶伟军,曹新平,李爱菊,任玉峰,陈凯,张志斌.插植调强近距离放射治疗复发性宫颈癌的临床研究[J].中华肿瘤防治杂志,2009,16(18):1427-1429. 被引量:19
  • 4马绍康,高菊珍,吴令英,王亚菲,张宏志,黄曼妮.宫颈癌复发肿瘤适形照射联合化疗30例临床观察[J].中国肿瘤临床,2006,33(2):96-98. 被引量:25
  • 5陈东福等著,殷蔚伯,谷铣之.肿瘤放射治疗学[M]中国协和医科大学出版社,2002.
  • 6Bazhenov AG,Guseǐnov KD,Khadzhimba AV,et al.Results of treatment for recurrent cancer of the uterine cervix. Voprosy Onkologii . 2009
  • 7Beadle BM,Jhingran A,Yom SS,et al.Patterns of regional recurrence after definitive radiotherapy for cervical cancer. International Journal of Radiation Oncology Biology Physics . 2010
  • 8Haie-Meder C,Mazeron R,Verezesan O,et al.Three-dimensional brachytherapy optimization techniques in the treatment of patients with cervix cancer. Cancer Radiotherapie . 2009
  • 9Narayan K,Barkati M,van Dyk S,et al.Image-guided brachytherapy for cervix cancer:from Manchester to Melbourne. Expert Review of Anticancer Therapy . 2010
  • 10Badakh DK,,Grover AH.Reirradiation with high-dose-rate remote afterloading brachytherapy implant in patientswith loaclly recurrent or residual cervical carcinoma. JCancer Res Ther . 2009

二级参考文献36

  • 1何剑莉,阎钢,海平.绝经前期ⅡB~ⅣA期宫颈癌综合治疗临床分析[J].肿瘤防治杂志,2004,11(9):952-954. 被引量:1
  • 2杨晓霞,韩云青.24例复发宫颈癌的化疗疗效分析[J].医药论坛杂志,2005,26(9):32-33. 被引量:4
  • 3金志红,廖革望,江宁.复发、转移的年轻妇女宫颈癌91例临床分析[J].实用癌症杂志,2006,21(5):502-503. 被引量:6
  • 4闻强,朱笕青.晚期或复发宫颈癌化疗进展[J].国外医学(妇产科学分册),2007,34(3):180-183. 被引量:8
  • 5Hong JH,Tsai CS,Lai CH,et al.Recurrent squamous cell carcinoma of cervix after definitive radiotherapy[J].Int J Radiat Oncol Biol Phys,2004,60(1):249~257.
  • 6Wang CH,Lai CH,Huang HJ,et al.Recuurent cervical carcinoma after primary radical surgery[J].Am J Obstet Gynecol,1999,181 (3):518~ 524.
  • 7Grigsby PW,Vest ML,Perez CA.Recurrent carcinoma of the cervix exclusively in the paraaortic nodes following radiation therapy[J].Int J Radiat Oncol Biol Phys,1994,28(2):451~455.
  • 8Singh AK,Grigsby PW,Rader JS,et al.Cervix carcinoma,concurrent chemoradiotherapy,and salvge of isolated paraaortic lymph node recurrence[J].Int J Radiat Oncol Biol Phys,2005,61(2):450~455.
  • 9Moore DH,BlessingJA,McQuellon RP,et al.Phase Ⅲ study of cisplatin with or without Paclitaxel in stage IVB,recurrent,or persistent squamous cell carcinoma of the cervix:A Gynecologic Oncology Group study[J].J Clin Oncol,2004,22(15):3113~3119.
  • 10Tsuda H,Hashiguchi Y,Nishimura S,et al.Phase Ⅰ-Ⅱ study of irinotecan (CPT-Ⅱ) plus nedaplatin (254-S) with recombinat human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer[J].Br J Cancer,2004,91(6):1032~1037.

共引文献50

同被引文献66

  • 1包德强,黄超红,张钰瑜,银正民,李斌,谢聘婷.复发性宫颈癌30例三维适形放射治疗的疗效观察[J].实用癌症杂志,2010,25(5):487-488. 被引量:7
  • 2Susan B, Peter B, Gerry L, et al. Cervical brachytherapy utilizing ring applicator: comparison of standard and conformal loading. Int J Radiat Oncol Biol Phys, 2005, 63(1) : 934-939.
  • 3Dimopouios JC, Kirisits C, Petrie P, et al. The Vienna applicator for combined intraeavitary and interstitial braehytherapy of cervical cancer: clinical feasibility and preliminary results. Int J Radiat Oneol Biol Phys,2006,66 ( 1 ) : 83-90.
  • 4Akilan K. Tomography versus magnetic resonance imaging-based contouring in cervical cancer brachy-therapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oneol Biol Phys ,2007 ,68 (2) : 491-498.
  • 5Christian K, Stefan L, Johannes D, et al, The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning and dosimetric results. Int J Radiat Oncol Biol Phys, 2006,65 (2) : 624-630.
  • 6Christian K, Richard P, Stefan L, et al. Dose and volume parameters for MRI-based treatment planning in intercavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phi's, 2005,62(3) : 901-911.
  • 7Firuza D, Bhavana R, Indranil M, et al. High-dose-rate hrachytherapy in uterine cervical carcinoma. Int J Radiat Oncol Biol Phys ,2005,62 ( 1 ) : 125-130.
  • 8Wang N, Wang K. Radiochemotherapy versus radiothe- rapy in locally advanced cervical cancer: a meta-analysis [ J 1. Arch Gynecol Obstet,2011,283 ( 1 ) : 103 - 108.
  • 9Hsieh CH, Tsai SJ, Chiou WY, et al. Better survival with three-dimensional conformal radiotherapy than with conventional radiotherapy for cervical cancer: a popula- tion-based study[ J ]. ISRN Oncol, 2013, doi : 10.11.55/ 2013/729819.
  • 10Erpolat OP, Alco G, Caglar HB, et al. Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradio- therapy : a national multi-center study [ J ]. Eur J Gynaecol Oncol,2014,35( 1 ) :62 -66.

引证文献10

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部